FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium)

This FITC-conjugated, monomeric amyloid beta (1-42) peptide is a critical research tool for studying Alzheimer's disease mechanisms. It is extensively used in vitro for fluorescence-based binding assays, cellular uptake studies, and high-throughput drug screening, as well as in ex vivo imaging applications to track Aβ localization and aggregation.